Andrea Díaz-Tejedor

4PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 11, 2024
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands.

Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad

|Apr 03, 2021
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.

Esperanza M Algarín, Dalia Quwaider, Francisco J Campos-Laborie

|Apr 03, 2021
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression.

Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig

|Nov 27, 2019
Biological Background of Resistance to Current Standards of Care in Multiple Myeloma.

Pedro Mogollón, Andrea Díaz-Tejedor, Esperanza M Algarín

Pageof 1

Frequent Collaborators

4 joint publications

Teresa Paíno

4 joint publications

Mercedes Garayoa

3 joint publications

Enrique M Ocio

2 joint publications

Pedro Mogollón